← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Biokier, Inc.
Chapel Hill, NC
$5,162,999
Total funding
2
Grants
Funding over time
peak $1.1M · FY2015–24$2M$1.5M$1M$500K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$5,162,999 · 2
By mechanism
R44$4,727,117 · 1
R43$435,882 · 1
Investigators at Biokier, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Development of an oral therapeutic to mimic the anti-diabetic effects of gastric bypass surgery$1,132,870
R44 · FY2017 · DK
Development of an oral therapeutic to mimic the anti-diabetic effects of gastric bypass surgery$999,864
R44 · FY2019 · DK
Development of an oral therapeutic to mimic the anti-diabetic effects of gastric bypass surgery$999,795
R44 · FY2020 · DK
Development of an oral therapeutic to mimic the anti-diabetic effects of gastric bypass surgery$999,710
R44 · FY2021 · DK
Clinical development of a colon-targeted butyrate tablet to evaluate effects on cholesterol and trimethyl amine oxide in subjects at risk for cardiovascular disease$435,882
R43 · FY2024 · HL
Development of an oral therapeutic to mimic the anti-diabetic effects of gastric bypass surgery$250,402
R44 · FY2018 · DK
Development of an oral therapeutic to mimic the anti-diabetic effects of gastric bypass surgery$224,486
R44 · FY2015 · DK
Development of an oral therapeutic to mimic the anti-diabetic effects of gastric bypass surgery$119,990
R44 · FY2018 · DK